1Platelet Receptor Inhibition in Ischemic Syndrome Management in Patients Limited by Unstable Signs and Symptoms (PRISM-PLUS) Study Investigators.Inhibition of the platelet glycoprotein Ⅱ b/Ⅲa receptor with tirofiban in unstable angina and non-Q-wave myocardial infarction.N Engl J Med,1998,338:1488-1497.
2The RESTORE Investigators.Randomized Efficacy Study of Tirofiban for Outcomes and restenosis.Effects of platelet glycoprotein Ⅱ b/Ⅲ a blockade with tirofiban on adverse cardiac events in patients with unstable angina or acute myocardial infarction undergoing coronary angioplasty.Circulation,1997,96:1445-1453.
3Bougie DW,Wilker PR,Wuitschick ED,et al.Acute thrombocytopenia after treatment with tirofiban or eptifibatide is associated with antibodies specific for ligand-occupied CP Ⅱ b/ Ⅲa.Blood,2002,100:2071-2076.
4Kelton JG.The pathophysiology of heparin-induced thrombocytopenia:biological basis for treatment Chest,2005,127 (2 Suppl):9S-20S.
5Razakjr OA,Tan HC,Yip WL,et al.Predictors of bleeding complications and thrombocytopenia with the use of abciximab during percutaneous coronary intervention.J Interv Cardiol,2005,18:33-37.
5Bougie DW, Wilker PR, Wuitschick ED, et al. Acutethrombocytopenia after treatment with tirofiban or eptifibatideis associated with antibodies specific for ligand-occupiedGPIIb/IIIa[J]. Blood, 2002,100(6):2071-2076.
6Said SM,Hahn J,Schleyer E,et al. Glycoprotein Ilb/IIIainhibitor-induced thrombocytopenia : diagnosis and treatment[J]. Clin Res Cardiol, 2007 ,96(2) : 61-69.
7Sakellariou D,Pastromas S,Koulouris S,et al. First reportof tirofiban-induced anemia (found in combination with severethrombocytopenia) [J]. Tex Heart Inst J,2009,36(1): 55-57.
8Yurtdas M, Yaylali YT, Aladag N, et al. Acute seriousfor primary angioplasty [J]. Case Rep Med,2014, 2014 :190149.
